$PTHN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Patheon N.V..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Patheon N.V.. Get notifications about new insider transactions in Patheon N.V. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2017 | PTHN | Patheon N.V. | Lagarde Michel | President | Option Exercise | D | 26.49 | 110,402 | 2,924,549 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Lagarde Michel | President | Sell | U | 0.00 | 245,939 | 0 | 0 | 245.9 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Wilson Dean Frederick | Chief Accounting Of ... | Sell | U | 0.00 | 126,518 | 0 | 0 | 126.5 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Option Exercise | D | 26.49 | 32,287 | 855,283 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Sell | U | 35.00 | 373,754 | 13,081,390 | 0 | 373.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Sell | J | 0.00 | 191,772 | 0 | 0 | 191.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Sell | U | 0.00 | 12,420 | 0 | 191,772 | 204.2 K to 191.8 K (-6.08 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Option Exercise | D | 26.49 | 17,174 | 454,939 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Option Exercise | D | 21.00 | 21,786 | 457,506 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Sell | U | 0.00 | 13,112 | 0 | 0 | 13.1 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Option Exercise | D | 26.49 | 32,630 | 864,369 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Sell | U | 35.00 | 129,595 | 4,535,825 | 0 | 129.6 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Sell | J | 0.00 | 219,330 | 0 | 0 | 219.3 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Sell | U | 0.00 | 12,552 | 0 | 219,330 | 231.9 K to 219.3 K (-5.41 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | SCHNEIER CRAIG ERIC | EVP and Chief Talen ... | Option Exercise | D | 21.00 | 96,455 | 2,025,555 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | SCHNEIER CRAIG ERIC | EVP and Chief Talen ... | Sell | U | 35.00 | 48,755 | 1,706,425 | 0 | 48.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Option Exercise | D | 26.49 | 26,791 | 709,694 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Sell | U | 35.00 | 286,585 | 10,030,475 | 0 | 286.6 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Sell | J | 0.00 | 161,543 | 0 | 0 | 161.5 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Sell | U | 0.00 | 10,306 | 0 | 161,543 | 171.8 K to 161.5 K (-6.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Option Exercise | D | 26.49 | 29,195 | 773,376 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Sell | U | 35.00 | 330,169 | 11,555,915 | 0 | 330.2 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Sell | J | 0.00 | 261,322 | 0 | 0 | 261.3 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Sell | U | 0.00 | 11,231 | 0 | 261,322 | 272.6 K to 261.3 K (-4.12 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | Chief Executive Off ... | Option Exercise | D | 26.49 | 242,885 | 6,434,024 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | Chief Executive Off ... | Sell | U | 35.00 | 2,615,089 | 91,528,115 | 0 | 2.6 M to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | Chief Executive Off ... | Sell | J | 0.00 | 906,858 | 0 | 0 | 906.9 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | Chief Executive Off ... | Sell | U | 0.00 | 93,432 | 0 | 906,858 | 1 M to 906.9 K (-9.34 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Global Sales a ... | Option Exercise | D | 26.49 | 28,508 | 755,177 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Global Sales a ... | Sell | U | 35.00 | 373,754 | 13,081,390 | 0 | 373.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Global Sales a ... | Sell | J | 0.00 | 191,772 | 0 | 0 | 191.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Global Sales a ... | Sell | U | 0.00 | 10,966 | 0 | 191,772 | 202.7 K to 191.8 K (-5.41 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Grant Stuart | EVP and CFO | Sell | U | 35.00 | 566,603 | 19,831,105 | 0 | 566.6 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Grant Stuart | EVP and CFO | Sell | J | 0.00 | 196,485 | 0 | 0 | 196.5 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality/Contin ... | Option Exercise | D | 26.49 | 18,400 | 487,416 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality/Contin ... | Sell | U | 35.00 | 305,094 | 10,678,290 | 0 | 305.1 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality/Contin ... | Sell | J | 0.00 | 105,800 | 0 | 0 | 105.8 K to 0 (-100.00 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality/Contin ... | Sell | U | 0.00 | 7,078 | 0 | 105,800 | 112.9 K to 105.8 K (-6.27 %) |
| Aug 31 2017 | PTHN | Patheon N.V. | COTTIER GILLES | President, Pharma D ... | Option Exercise | D | 26.49 | 123,754 | 3,278,243 | 0 | |
| Aug 31 2017 | PTHN | Patheon N.V. | COTTIER GILLES | President, Pharma D ... | Sell | U | 0.00 | 70,141 | 0 | 0 | 70.1 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Tanda Stephan B. | Director | Sell | U | 35.00 | 4,659 | 163,065 | 0 | 4.7 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Pisano Gary P. | Director | Sell | U | 35.00 | 17,447 | 610,645 | 0 | 17.4 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Sell | U | 35.00 | 27,447 | 960,645 | 0 | 27.4 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Sell | U | 35.00 | 62,000 | 2,170,000 | 0 | 62 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 40,287 | 1,410,045 | 0 | 40.3 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 19,985,589 | 699,495,615 | 0 | 20 M to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 7,013,339 | 245,466,865 | 0 | 7 M to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 4,996,397 | 174,873,895 | 0 | 5 M to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 5,975,840 | 209,154,400 | 0 | 6 M to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Sell | U | 35.00 | 24,455,392 | 855,938,720 | 0 | 24.5 M to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Hayes William B | Director | Sell | U | 35.00 | 17,447 | 610,645 | 0 | 17.4 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Sell | U | 35.00 | 16,864 | 590,240 | 0 | 16.9 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Eykerman Philip | Director | Sell | U | 35.00 | 28,000 | 980,000 | 0 | 28 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Daley Pamela | Director | Sell | U | 35.00 | 67,120 | 2,349,200 | 0 | 67.1 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Cogut Charles I | Director | Sell | U | 35.00 | 4,061 | 142,135 | 0 | 4.1 K to 0 (-100.00 %) |
| Aug 30 2017 | PTHN | Patheon N.V. | Koninklijke DSM N.V. | Sell | U | 35.00 | 48,697,292 | 1,704,405,220 | 0 | 48.7 M to 0 (-100.00 %) | |
| Jul 24 2017 | PTHN | Patheon N.V. | Lagarde Michel | President | Payment of Exercise | F | 34.90 | 34,625 | 1,208,413 | 245,939 | 280.6 K to 245.9 K (-12.34 %) |
| Jul 24 2017 | PTHN | Patheon N.V. | SCHNEIER CRAIG ERIC | Executive Vice Pres ... | Payment of Exercise | F | 34.90 | 5,914 | 206,399 | 48,755 | 54.7 K to 48.8 K (-10.82 %) |
| Jul 24 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Payment of Exercise | F | 34.90 | 786 | 27,431 | 13,112 | 13.9 K to 13.1 K (-5.66 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Option Exercise | A | 26.49 | 17,174 | 454,939 | 17,174 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Torres Raul Cardona | SVP, Quality | Grant | A | 0.00 | 6,606 | 0 | 13,898 | 7.3 K to 13.9 K (+90.59 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | CEO | Option Exercise | A | 26.49 | 242,885 | 6,434,024 | 242,885 | |
| Mar 27 2017 | PTHN | Patheon N.V. | MULLEN JAMES C | CEO | Grant | A | 0.00 | 93,432 | 0 | 1,000,290 | 906.9 K to 1 M (+10.30 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Lagarde Michel | President | Option Exercise | A | 26.49 | 110,402 | 2,924,549 | 110,402 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Lagarde Michel | President | Grant | A | 0.00 | 42,469 | 0 | 280,564 | 238.1 K to 280.6 K (+17.84 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Option Exercise | A | 26.49 | 29,195 | 773,376 | 29,195 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Grant | A | 0.00 | 11,231 | 0 | 272,553 | 261.3 K to 272.6 K (+4.30 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Option Exercise | A | 26.49 | 26,791 | 709,694 | 26,791 | |
| Mar 27 2017 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Grant | A | 0.00 | 10,306 | 0 | 171,849 | 161.5 K to 171.8 K (+6.38 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Option Exercise | A | 26.49 | 32,630 | 864,369 | 32,630 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Grant | A | 0.00 | 12,552 | 0 | 231,882 | 219.3 K to 231.9 K (+5.72 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality & Impr ... | Option Exercise | A | 26.49 | 18,400 | 487,416 | 18,400 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality & Impr ... | Grant | A | 0.00 | 7,078 | 0 | 112,878 | 105.8 K to 112.9 K (+6.69 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Option Exercise | A | 26.49 | 32,287 | 855,283 | 32,287 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Grant | A | 0.00 | 12,420 | 0 | 204,192 | 191.8 K to 204.2 K (+6.48 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Sales & Market ... | Option Exercise | A | 26.49 | 28,508 | 755,177 | 28,508 | |
| Mar 27 2017 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Sales & Market ... | Grant | A | 0.00 | 10,966 | 0 | 202,738 | 191.8 K to 202.7 K (+5.72 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Wilson Dean Frederick | Chief Accounting Of ... | Grant | A | 0.00 | 8,519 | 0 | 126,518 | 118 K to 126.5 K (+7.22 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Pisano Gary P. | Director | Grant | A | 0.00 | 6,229 | 0 | 17,447 | 11.2 K to 17.4 K (+55.53 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Grant | A | 0.00 | 6,229 | 0 | 17,447 | 11.2 K to 17.4 K (+55.53 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Grant | A | 0.00 | 897 | 0 | 16,864 | 16 K to 16.9 K (+5.62 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Grant | A | 0.00 | 6,229 | 0 | 15,967 | 9.7 K to 16 K (+63.97 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Hayes William B | Director | Grant | A | 0.00 | 6,229 | 0 | 17,447 | 11.2 K to 17.4 K (+55.53 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Tanda Stephan B. | Director | Grant | A | 0.00 | 4,659 | 0 | 4,659 | 0 to 4.7 K |
| Mar 27 2017 | PTHN | Patheon N.V. | Daley Pamela | Director | Grant | A | 0.00 | 873 | 0 | 18,320 | 17.4 K to 18.3 K (+5.00 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Daley Pamela | Director | Grant | A | 0.00 | 6,229 | 0 | 17,447 | 11.2 K to 17.4 K (+55.53 %) |
| Mar 27 2017 | PTHN | Patheon N.V. | Cogut Charles I | Director | Grant | A | 0.00 | 4,061 | 0 | 4,061 | 0 to 4.1 K |
| Nov 02 2016 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Payment of Exercise | F | 25.61 | 687 | 17,594 | 11,218 | 11.9 K to 11.2 K (-5.77 %) |
| Nov 02 2016 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Buy | M | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Nov 02 2016 | PTHN | Patheon N.V. | Pisano Gary P. | Director | Payment of Exercise | F | 25.61 | 687 | 17,594 | 11,218 | 11.9 K to 11.2 K (-5.77 %) |
| Nov 02 2016 | PTHN | Patheon N.V. | Pisano Gary P. | Director | Buy | M | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Nov 02 2016 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Payment of Exercise | F | 25.61 | 2,167 | 55,497 | 9,738 | 11.9 K to 9.7 K (-18.20 %) |
| Nov 02 2016 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Buy | M | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Nov 02 2016 | PTHN | Patheon N.V. | Hayes William B | Director | Payment of Exercise | F | 25.61 | 687 | 17,594 | 11,218 | 11.9 K to 11.2 K (-5.77 %) |
| Nov 02 2016 | PTHN | Patheon N.V. | Hayes William B | Director | Buy | M | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Nov 02 2016 | PTHN | Patheon N.V. | Daley Pamela | Director | Payment of Exercise | F | 25.61 | 687 | 17,594 | 11,218 | 11.9 K to 11.2 K (-5.77 %) |
| Nov 02 2016 | PTHN | Patheon N.V. | Daley Pamela | Director | Buy | M | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Oct 03 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 29.80 | 5,000 | 149,000 | 62,000 | 57 K to 62 K (+8.77 %) |
| Oct 03 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 29.30 | 5,000 | 146,500 | 57,000 | 52 K to 57 K (+9.62 %) |
| Sep 28 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 29.61 | 5,000 | 148,050 | 52,000 | 47 K to 52 K (+10.64 %) |
| Sep 28 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 29.65 | 5,000 | 148,250 | 47,000 | 42 K to 47 K (+11.90 %) |
| Sep 28 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 29.65 | 5,000 | 148,250 | 42,000 | 37 K to 42 K (+13.51 %) |
| Sep 14 2016 | PTHN | Patheon N.V. | LEVY PAUL S | Director | Buy | P | 28.01 | 37,000 | 1,036,370 | 37,000 | 0 to 37 K |
| Jul 28 2016 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Buy | P | 19.85 | 40,287 | 799,496 | 40,287 | 0 to 40.3 K |
| Jul 28 2016 | PTHN | Patheon N.V. | JLL Associates G.P. V (Patheon ... | 10% Owner | Buy | P | 19.85 | 775,443 | 15,388,666 | 24,455,392 | 23.7 M to 24.5 M (+3.27 %) |
| Jul 28 2016 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Buy | P | 19.85 | 10,000 | 198,450 | 21,905 | 11.9 K to 21.9 K (+84.00 %) |
| Jul 28 2016 | PTHN | Patheon N.V. | Daley Pamela | Director | Buy | P | 19.85 | 48,800 | 968,436 | 60,705 | 11.9 K to 60.7 K (+409.91 %) |
| Jul 28 2016 | PTHN | Patheon N.V. | Koninklijke DSM N.V. | Sell | S | 19.85 | 4,761,905 | 94,500,005 | 48,697,292 | 53.5 M to 48.7 M (-8.91 %) | |
| Jul 25 2016 | PTHN | Patheon N.V. | Eykerman Philip | Director | Buy | P | 25.00 | 28,000 | 700,000 | 28,000 | 0 to 28 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Wilson Dean Frederick | Chief Accounting Of ... | Grant | A | 0.00 | 117,999 | 0 | 117,999 | 0 to 118 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Utiger Lukas | President, Drug Sub ... | Grant | A | 0.00 | 191,772 | 0 | 191,772 | 0 to 191.8 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Sherbet Eric | General Counsel and ... | Grant | A | 0.00 | 219,330 | 0 | 219,330 | 0 to 219.3 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Pisano Gary P. | Director | Grant | A | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | New Rebecca Holland | EVP, Enterprise Ope ... | Grant | A | 0.00 | 161,543 | 0 | 161,543 | 0 to 161.5 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Negron Francisco R. | President, Drug Pro ... | Grant | A | 0.00 | 261,322 | 0 | 261,322 | 0 to 261.3 K |
| Jul 22 2016 | PTHN | Patheon N.V. | MULLEN JAMES C | Chief Executive Off ... | Grant | A | 0.00 | 906,858 | 0 | 906,858 | 0 to 906.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | McMullen Jeffrey P | Director | Grant | A | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | LYTTON MICHAEL | EVP, Corp Developme ... | Grant | A | 0.00 | 227,201 | 0 | 227,201 | 0 to 227.2 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Lehmann Michael J. | EVP, Global Sales a ... | Grant | A | 0.00 | 191,772 | 0 | 191,772 | 0 to 191.8 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Lagarde Michel | President | Grant | A | 0.00 | 238,095 | 0 | 238,095 | 0 to 238.1 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Hayes William B | Director | Grant | A | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | HASLER HANS PETER | Director | Grant | A | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Grant Stuart | EVP and CFO | Grant | A | 0.00 | 196,485 | 0 | 196,485 | 0 to 196.5 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Gill Harry R III | SVP, Quality/Contin ... | Grant | A | 0.00 | 105,800 | 0 | 105,800 | 0 to 105.8 K |
| Jul 22 2016 | PTHN | Patheon N.V. | Daley Pamela | Director | Grant | A | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
| Jul 22 2016 | PTHN | Patheon N.V. | COTTIER GILLES | President, Pharma D ... | Option Exercise | A | 21.00 | 123,754 | 2,598,834 | 123,754 | |
| Jul 22 2016 | PTHN | Patheon N.V. | COTTIER GILLES | President, Pharma D ... | Grant | A | 0.00 | 70,141 | 0 | 70,141 | 0 to 70.1 K |
Page: 1